已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds

溶瘤病毒 医学 放射治疗 脑瘤 肿瘤微环境 胶质母细胞瘤 免疫疗法 癌症研究 生物信息学 神经科学 免疫系统 免疫学 生物 内科学 病理
作者
Sweety Asija,Abhishek Chatterjee,Sandhya Yadav,Godhanjali Chekuri,Atharva Karulkar,Ankesh Kumar Jaiswal,Jayant Sastri Goda,Rahul Purwar
出处
期刊:International Reviews of Immunology [Taylor & Francis]
卷期号:41 (6): 582-605 被引量:22
标识
DOI:10.1080/08830185.2022.2101647
摘要

The aggressive and recurrent nature of glioblastoma is multifactorial and has been attributed to its biological heterogeneity, dysfunctional metabolic signaling pathways, rigid blood–brain barrier, inherent resistance to standard therapy due to the stemness property of the gliomas cells, immunosuppressive tumor microenvironment, hypoxia and neoangiogenesis which are very well orchestrated and create the tumor's own highly pro-tumorigenic milieu. Once the relay of events starts amongst these components, eventually it becomes difficult to control the cascade using only the balanced contemporary care of treatment consisting of maximal resection, radiotherapy and chemotherapy with temozolamide. Over the past few decades, implementation of contemporary treatment modalities has shown benefit to some extent, but no significant overall survival benefit is achieved. Therefore, there is an unmet need for advanced multifaceted combinatorial strategies. Recent advances in molecular biology, development of innovative therapeutics and novel delivery platforms over the years has resulted in a paradigm shift in gliomas therapeutics. Decades of research has led to emergence of several treatment molecules, including immunotherapies such as immune checkpoint blockade, oncolytic virotherapy, adoptive cell therapy, nanoparticles, CED and BNCT, each with the unique proficiency to overcome the mentioned challenges, present research. Recent years are seeing innovative combinatorial strategies to overcome the multifactorial resistance put forth by the GBM cell and its TME. This review discusses the contemporary and the investigational combinatorial strategies being employed to treat GBM and summarizes the evidence accumulated till date.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
NexusExplorer应助XudongHou采纳,获得10
1秒前
1秒前
DSFSD发布了新的文献求助10
2秒前
2秒前
ssk发布了新的文献求助10
3秒前
fatdudu发布了新的文献求助10
5秒前
Glamic发布了新的文献求助10
6秒前
粗心的绾绾应助SiDi采纳,获得30
6秒前
香蕉觅云应助SiDi采纳,获得30
6秒前
小蘑菇应助科研通管家采纳,获得10
8秒前
研友_VZG7GZ应助科研通管家采纳,获得10
8秒前
ding应助科研通管家采纳,获得10
8秒前
YifanWang应助科研通管家采纳,获得30
8秒前
8秒前
8秒前
DSFSD完成签到,获得积分10
9秒前
斯文败类应助ssk采纳,获得10
9秒前
9秒前
12秒前
12秒前
小小鱼完成签到 ,获得积分10
12秒前
zf2023发布了新的文献求助10
13秒前
time4323发布了新的文献求助10
15秒前
18秒前
19秒前
20秒前
SiDi完成签到,获得积分10
21秒前
缥缈飞鸟发布了新的文献求助30
25秒前
25秒前
Williams发布了新的文献求助10
26秒前
阿彪完成签到,获得积分20
27秒前
27秒前
28秒前
29秒前
钮南琴完成签到,获得积分10
30秒前
ZHH完成签到,获得积分10
30秒前
xyf发布了新的文献求助10
30秒前
绿琦完成签到,获得积分10
31秒前
高分求助中
Technologies supporting mass customization of apparel: A pilot project 600
Izeltabart tapatansine - AdisInsight 500
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
Epigenetic Drug Discovery 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3815420
求助须知:如何正确求助?哪些是违规求助? 3359189
关于积分的说明 10400678
捐赠科研通 3076839
什么是DOI,文献DOI怎么找? 1690041
邀请新用户注册赠送积分活动 813577
科研通“疑难数据库(出版商)”最低求助积分说明 767674